Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Lung Cancer

  Free Subscription


Articles published in J Thorac Cardiovasc Surg

Retrieve available abstracts of 323 articles:
HTML format



Single Articles


    April 2021
  1. GROTH SS, Ripley RT
    Commentary: Cisplatin-induced nephrotoxicity following cytoreductive surgery and heated intraoperative chemotherapy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1519-1520.
    PubMed    


  2. EBRIGHT MI
    Commentary: Acute kidney injury after intrapleural cisplatin: Minimizing collateral damage.
    J Thorac Cardiovasc Surg. 2021;161:1522-1523.
    PubMed    


  3. BRIBRIESCO A
    Commentary: Winning the battle for local control without losing war for survival against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1520-1522.
    PubMed    


  4. VARELA G
    Commentary: Extended disease, but still not the end for patients.
    J Thorac Cardiovasc Surg. 2021;161:1507-1508.
    PubMed    


  5. STILES BM
    Commentary: Think systemically, act locally.
    J Thorac Cardiovasc Surg. 2021;161:1505-1506.
    PubMed    


  6. VEERAMACHANENI NK
    Commentary: Ground-glass opacity-an unexpected silver lining.
    J Thorac Cardiovasc Surg. 2021;161:1481-1482.
    PubMed    


  7. YENDAMURI S
    Commentary: A picture really is worth a thousand words.
    J Thorac Cardiovasc Surg. 2021;161:1482-1483.
    PubMed    


  8. HOD T, Freedberg KJ, Motwani SS, Chen M, et al
    Acute kidney injury after cytoreductive surgery and hyperthermic intraoperative cisplatin chemotherapy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2021;161:1510-1518.
    PubMed     Abstract available


    March 2021
  9. TONG BC
    Commentary: Safety first!
    J Thorac Cardiovasc Surg. 2021;161:803-804.
    PubMed    


  10. RAYMOND DP
    Commentary: We need more surgeons!
    J Thorac Cardiovasc Surg. 2021;161:804-805.
    PubMed    


  11. IMAI T, Weksler B
    Commentary: Eurolung score as a predictor of long-term survival: It is not all about the tumor.
    J Thorac Cardiovasc Surg. 2021;161:788-789.
    PubMed    


  12. DONAHOE LL, Nason GJ, Bedard PL, Hansen AR, et al
    Pathologic concordance of resected metastatic nonseminomatous germ cell tumors in the chest.
    J Thorac Cardiovasc Surg. 2021;161:856-868.
    PubMed     Abstract available


  13. SHEMANSKI KA, Farias A, Lieu D, Kim AW, et al
    Understanding thoracic surgeons' perceptions of administrative database analyses and guidelines in clinical decision-making.
    J Thorac Cardiovasc Surg. 2021;161:807-816.
    PubMed     Abstract available


    February 2021
  14. IMAI T, Weksler B
    Commentary: Open or VATS? Roll up your sleeve.
    J Thorac Cardiovasc Surg. 2021;161:414-415.
    PubMed    


  15. CHUDGAR NP, Bott MJ
    Commentary: Minimally invasive sleeve lobectomy: Time to roll up our "sleeves" and learn something new?
    J Thorac Cardiovasc Surg. 2021;161:415-416.
    PubMed    


  16. RIPLEY RT
    Commentary: Drawing the target after shooting the arrow: The importance of trial design.
    J Thorac Cardiovasc Surg. 2021;161:443-444.
    PubMed    


  17. GERACI TC, Ng T
    Commentary: Overreliance of propensity-score matched studies in thoracic surgery.
    J Thorac Cardiovasc Surg. 2021;161:417-418.
    PubMed    


    January 2021
  18. VEERAMACHANENI NK
    Commentary: Computed tomography screening for lung cancer at large in China: Early cure or definitive overtreatment?
    J Thorac Cardiovasc Surg. 2021 Jan 13. pii: S0022-5223(21)00047.
    PubMed    


  19. YE T, Chen H
    Commentary: The ground-glass opacity: "The savior" for lung cancer?
    J Thorac Cardiovasc Surg. 2021 Jan 8. pii: S0022-5223(21)00014.
    PubMed    


    December 2020
  20. WATANABE Y, Hattori A, Nojiri S, Matsunaga T, et al
    Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Dec 29. pii: S0022-5223(20)33443.
    PubMed     Abstract available


  21. VAN RAEMDONCK D, Decaluwe H, De Leyn P, Nackaerts K, et al
    Commentary: Do we need to search for a patient's cigarettes or just count his or her wrinkles when counseling for lung cancer resection?
    J Thorac Cardiovasc Surg. 2020 Dec 25. pii: S0022-5223(20)33404.
    PubMed    


  22. HEIDEN BT, Subramanian MP, Puri V, Kozower BD, et al
    Striking a balance: Surveillance of non-small cell lung cancer after resection.
    J Thorac Cardiovasc Surg. 2020 Dec 10. pii: S0022-5223(20)33342.
    PubMed    


  23. AL NATOUR RH, He C, Clark MJ, Welsh R, et al
    The influence of tobacco load versus smoking status on outcomes following lobectomy for lung cancer in a statewide quality collaborative.
    J Thorac Cardiovasc Surg. 2020 Dec 10. pii: S0022-5223(20)33305.
    PubMed     Abstract available


  24. ABBAS AE
    Commentary: The value of close surveillance after lung cancer surgery: How absence of evidence is not evidence of absence.
    J Thorac Cardiovasc Surg. 2020 Dec 3. pii: S0022-5223(20)33213.
    PubMed    


  25. HENNON M, Groman A, Kumar A, Castaldo L, et al
    Correlation between perioperative outcomes and long-term survival for non-small lung cancer treated at major centers.
    J Thorac Cardiovasc Surg. 2020 Dec 3. pii: S0022-5223(20)33194.
    PubMed     Abstract available


  26. LIU C, Liao H, Guo C, Pu Q, et al
    Single-direction thoracoscopic basal segmentectomy.
    J Thorac Cardiovasc Surg. 2020;160:1586-1594.
    PubMed     Abstract available


    November 2020
  27. D'AMICO TA
    Commentary: Surgery for small cell lung cancer: This is the way.
    J Thorac Cardiovasc Surg. 2020 Nov 28. pii: S0022-5223(20)33173.
    PubMed    


  28. ZHOU N, Bott M, Park BJ, Vallieres E, et al
    Predictors of survival following surgical resection of limited-stage small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 27. pii: S0022-5223(20)33137.
    PubMed     Abstract available


  29. ONAITIS M
    Commentary: Survival after small cell lung cancer resection: Small opportunity?
    J Thorac Cardiovasc Surg. 2020 Nov 24. pii: S0022-5223(20)33131.
    PubMed    


  30. SWANSON SJ
    Commentary: Find, resect, and treat: The evolving early-stage small cell lung cancer story.
    J Thorac Cardiovasc Surg. 2020 Nov 21. pii: S0022-5223(20)33080.
    PubMed    


  31. SUN C, Anraku M, Kawahara T, Karasaki T, et al
    Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 19. pii: S0022-5223(20)33059.
    PubMed     Abstract available


  32. SUZUKI K, Watanabe SI, Wakabayashi M, Saji H, et al
    A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
    J Thorac Cardiovasc Surg. 2020 Nov 12. pii: S0022-5223(20)33043.
    PubMed     Abstract available


  33. SESTI J, Paul S
    Commentary: Burn, baby, burn.
    J Thorac Cardiovasc Surg. 2020;160:1348-1349.
    PubMed    


  34. KIM SS, Bharat A
    Commentary: Video-assisted thoracoscopic surgery versus robotic assisted surgery: Are we asking the right question?
    J Thorac Cardiovasc Surg. 2020;160:1374-1375.
    PubMed    


  35. LIN J
    Commentary: The wizard of OS: Is overall survival better after sublobar resection versus stereotactic radiation or ablation?
    J Thorac Cardiovasc Surg. 2020;160:1358-1359.
    PubMed    


  36. LANUTI M
    Commentary: Can big data effectively answer important clinical questions?
    J Thorac Cardiovasc Surg. 2020;160:1361-1362.
    PubMed    


  37. SONG KJ, Flores RM
    Commentary: Robot-assisted segmentectomy is safe and expensive-What is the debate?
    J Thorac Cardiovasc Surg. 2020;160:1373-1374.
    PubMed    


  38. DENLINGER CE
    Commentary: To wedge or not to wedge.
    J Thorac Cardiovasc Surg. 2020;160:1359-1360.
    PubMed    


    October 2020
  39. TSUTANI Y, Handa Y, Shimada Y, Ito H, et al
    Comparison of cancer control between segmentectomy and wedge resection in patients with clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 22. pii: S0022-5223(20)32833.
    PubMed     Abstract available


  40. BEAMER S, D'Cunha J
    Commentary: Using the entire toolbox for improved survival in anaplastic lymphoma kinase-positive non-small cell lung cancer: The next normal?
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32858.
    PubMed    


  41. MUENYI C, Ng T
    Commentary: Sublobar resection, closing in as the standard in surgical management for a subgroup of patients with lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32848.
    PubMed    


  42. MUNIAPPAN A
    Commentary: One size does not fit ALK-Targeted therapy, local ablation of recurrence, and improved outcomes after resection of ALK-positive lung cancer.
    J Thorac Cardiovasc Surg. 2020 Oct 17. pii: S0022-5223(20)32856.
    PubMed    


  43. LANUTI M
    Commentary: Comparing sleeve lobectomy with pneumonectomy for central lung cancer: A randomized study will never be conducted.
    J Thorac Cardiovasc Surg. 2020 Oct 13. pii: S0022-5223(20)32818.
    PubMed    


  44. SCARCI M, Raveglia F
    Commentary: Ground-glass opacity-dominant lung cancer. Is every R0 wedge resection always a good wedge resection?
    J Thorac Cardiovasc Surg. 2020 Oct 13. pii: S0022-5223(20)32830.
    PubMed    


  45. PASS HI
    Commentary: Tasting individual ingredients of meso soup: Can 'omics bring out the flavor?
    J Thorac Cardiovasc Surg. 2020;160:1084-1085.
    PubMed    


  46. SEVERSON DT, De Rienzo A, Bueno R
    Mesothelioma in the age of "Omics": Before and after The Cancer Genome Atlas.
    J Thorac Cardiovasc Surg. 2020;160:1078-1083.
    PubMed    


  47. RIPLEY RT
    Commentary: Filling up my truck from an oil tanker: Can big 'omic' data influence our clinical decisions?
    J Thorac Cardiovasc Surg. 2020;160:1086-1087.
    PubMed    


  48. DAVID EA, Atay SM
    Commentary: To scan or not to scan: No longer the question for mesothelioma patients after pleurectomy.
    J Thorac Cardiovasc Surg. 2020;160:1076-1077.
    PubMed    


  49. CAMERON RB
    Commentary: Mesothelioma: The Guinness world record holder in thromboembolism.
    J Thorac Cardiovasc Surg. 2020;160:1074-1075.
    PubMed    


  50. DEMMY TL
    Commentary: Positive pressure toward a negative trial?
    J Thorac Cardiovasc Surg. 2020;160:1062-1063.
    PubMed    


  51. CORSINI EM, Antonoff MB
    Commentary: Work in progress-Defining optimal surgical prehabilitation before lung resection.
    J Thorac Cardiovasc Surg. 2020;160:1060-1061.
    PubMed    


  52. DE LEON LE, Bravo-Iniguez CE, Fox S, Tarascio J, et al
    Routine surveillance for diagnosis of venous thromboembolism after pleurectomy for malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;160:1064-1073.
    PubMed     Abstract available


    September 2020
  53. HO H, Williamson C, Regis SM, Stock CT, et al
    Surgery and invasive diagnostic procedures for benign disease are rare in a large low-dose computed tomography lung cancer screening program.
    J Thorac Cardiovasc Surg. 2020 Sep 8. pii: S0022-5223(20)32573.
    PubMed     Abstract available


  54. RAKOVICH G, Bujold A
    The "multispecialty clinic": Toward a new paradigm in thoracic oncology?
    J Thorac Cardiovasc Surg. 2020;160:e176-e177.
    PubMed    


  55. MORI M, Geirsson A
    Reply from authors: Identifying lessons that could be generalized across different disease burdens.
    J Thorac Cardiovasc Surg. 2020;160:e133-e134.
    PubMed    


  56. SONG KJ, Flores RM
    REPLY: ROBOTIC-ASSISTED SEGMENTECTOMY: DOING IT SIMPLY BECAUSE WE CAN?
    J Thorac Cardiovasc Surg. 2020;160:e176.
    PubMed    


  57. MADARIAGA ML, Gaissert HA
    Reply from authors: The many benefits of a multidisciplinary evaluation of lung nodules.
    J Thorac Cardiovasc Surg. 2020;160:e177-e178.
    PubMed    


  58. ZHANG Y, Chen X, Li H
    Robotic or thoracoscopic segmentectomy: Each complements the other.
    J Thorac Cardiovasc Surg. 2020;160:e175.
    PubMed    


  59. VEERAMACHANENI NK
    Commentary: Minimally invasive sleeve lobectomy-from case report curiosity to standard of care?
    J Thorac Cardiovasc Surg. 2020;160:852-853.
    PubMed    


  60. CERFOLIO RJ
    Commentary: Why so many sleeve resections and pneumonectomies and why the nonabsorbable suture?
    J Thorac Cardiovasc Surg. 2020;160:847-848.
    PubMed    


  61. LAZZARO R, Patton B
    Commentary: Maximum surgery through minimal incisions.
    J Thorac Cardiovasc Surg. 2020;160:849-850.
    PubMed    


  62. MATTHEWS CR, Hess PJ
    Thirty-three, zero, nine.
    J Thorac Cardiovasc Surg. 2020;160:871-875.
    PubMed    


  63. CHU NQ, Liu R, Colby A, de Forcrand C, et al
    Paclitaxel-loaded expansile nanoparticles improve survival following cytoreductive surgery in pleural mesothelioma xenografts.
    J Thorac Cardiovasc Surg. 2020;160:e159-e168.
    PubMed     Abstract available


  64. ZHANG Y, Jheon S, Li H, Zhang H, et al
    Results of low-dose computed tomography as a regular health examination among Chinese hospital employees.
    J Thorac Cardiovasc Surg. 2020;160:824-831.
    PubMed     Abstract available


    August 2020
  65. STILES BM
    Commentary: Overcoming the dangerous narrative of computed tomography screening for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 28. pii: S0022-5223(20)32464.
    PubMed    


  66. BRUNELLI A, Chaudhuri N, Kefaloyannis M, Milton R, et al
    Eurolung risk score is associated with long-term survival after curative resection for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 24. pii: S0022-5223(20)32431.
    PubMed     Abstract available


  67. CHEN KN
    Commentary: Not only safety but also efficacy is required in repeat pulmonary resection for second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Aug 8. pii: S0022-5223(20)32360.
    PubMed    


  68. LIU C, Tian D, Pu Q
    Do not go too far when choosing intentional segmentectomy for small-sized lung cancers.
    J Thorac Cardiovasc Surg. 2020;160:e85-e86.
    PubMed    


  69. RAZI SS, Nguyen D, Villamizar N
    Reply from authors: Positive nodes after segmentectomy: Take a deep breath and give adjuvant treatment.
    J Thorac Cardiovasc Surg. 2020;160:e86-e87.
    PubMed    


  70. JEFFREY YANG CF, Berry MF
    Reply: The importance of appropriate selection for segmentectomy.
    J Thorac Cardiovasc Surg. 2020;160:e87.
    PubMed    


  71. LAZAR JF
    Commentary: How to "spot" a leopard: It's in the genes.
    J Thorac Cardiovasc Surg. 2020;160:e82-e83.
    PubMed    


  72. PATEL S, Kim AW
    Commentary: Standing on similar, but different, shoulders.
    J Thorac Cardiovasc Surg. 2020;160:e81-e82.
    PubMed    


  73. PENG S, Huang L, Zhao B, Zhou S, et al
    Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis.
    J Thorac Cardiovasc Surg. 2020;160:585-592.
    PubMed     Abstract available


  74. HUANG J, Wang A, Kang G, Li D, et al
    Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery.
    J Thorac Cardiovasc Surg. 2020;160:e91-e93.
    PubMed    


  75. FAN L, Yang H, Yu L, Wang Z, et al
    Multicenter, prospective, observational study of a novel technique for preoperative pulmonary nodule localization.
    J Thorac Cardiovasc Surg. 2020;160:532-539.
    PubMed     Abstract available


    July 2020
  76. D'ANDRILLI A, Rendina EA
    Commentary: Second ipsilateral metachronous lung cancer: What to do?
    J Thorac Cardiovasc Surg. 2020 Jul 24. pii: S0022-5223(20)32224.
    PubMed    


  77. HATTORI A, Matsunaga T, Watanabe Y, Fukui M, et al
    Repeated anatomical pulmonary resection for metachronous ipsilateral second non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 16. pii: S0022-5223(20)32150.
    PubMed     Abstract available


  78. ZAMBETTI BR, Ng T
    Commentary: Patient frailty also drives long-term outcomes after R0 resection for lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 14. pii: S0022-5223(20)32079.
    PubMed    


  79. SUDARSHAN M, Murthy SC
    Commentary: Using nutritional scoring systems to predict outcomes after lung cancer surgery: Food for thought.
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32051.
    PubMed    


  80. BAZHENOVA L, Urbanic J, Onaitis M
    Commentary: Epidermal growth factor receptor mutations in resectable lung cancer: What is the prognostic importance?
    J Thorac Cardiovasc Surg. 2020 Jul 13. pii: S0022-5223(20)32054.
    PubMed    


  81. WALLACE AF, Weksler B
    Commentary: Food for thought: Assessing the influence of malnutrition in patients with lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 10. pii: S0022-5223(20)32042.
    PubMed    


  82. NELSON DB, Antonoff MB
    Commentary: The prognostic value of Kirsten rat sarcoma viral oncogene mutation for non-small cell lung cancer: One size does not always fit all.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31990.
    PubMed    


  83. STILES BM, Sepesi B, Broderick SR, Bott MJ, et al
    Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jul 5. pii: S0022-5223(20)31987.
    PubMed    


  84. SALAZAR MC, Boffa DJ
    Commentary: The majority of minorities.
    J Thorac Cardiovasc Surg. 2020;160:272-273.
    PubMed    


  85. HAMMOUD ZT
    Commentary: Despair and disparity.
    J Thorac Cardiovasc Surg. 2020;160:275.
    PubMed    


  86. CORNWELL LD, Ripley RT
    Commentary: Beyond the eyeball test.
    J Thorac Cardiovasc Surg. 2020;160:285-286.
    PubMed    


  87. JONES GD, Tan KS, Caso R, Dycoco J, et al
    Time-varying analysis of readmission and mortality during the first year after pneumonectomy.
    J Thorac Cardiovasc Surg. 2020;160:247-255.
    PubMed     Abstract available


    June 2020
  88. TAKAHASHI M, Sowa T, Tokumasu H, Gomyoda T, et al
    Comparison of three nutritional scoring systems for outcomes after complete resection of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 29. pii: S0022-5223(20)31751.
    PubMed     Abstract available


  89. MUNIAPPAN A
    Commentary: Through the looking glass-radiomics and evaluation of early lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 26. pii: S0022-5223(20)31771.
    PubMed    


  90. LIN J
    Commentary: Mind the gap: Adherence to quality measures for stage I/II non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jun 26. pii: S0022-5223(20)31753.
    PubMed    


  91. TANG A, Ahmad U, Toth AJ, Bourdakos N, et al
    Non-small cell lung cancer in never- and ever-smokers: Is it the same disease?
    J Thorac Cardiovasc Surg. 2020 Jun 18. pii: S0022-5223(20)31395.
    PubMed     Abstract available


  92. GILES AE, Kidane B
    Commentary: Know your enemy-Understanding futility in the battle against malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2523-2524.
    PubMed    


  93. HOANG CD
    Commentary: Surgeon versus mesothelioma in a thoracic cage match.
    J Thorac Cardiovasc Surg. 2020;159:2522-2523.
    PubMed    


  94. ANDRADE R
    Commentary: Why do uniportal video-assisted thoracoscopic lobectomy?
    J Thorac Cardiovasc Surg. 2020;159:2496-2497.
    PubMed    


  95. BOFFA DJ, Salazar M
    Commentary: How surprising.
    J Thorac Cardiovasc Surg. 2020;159:2483-2484.
    PubMed    


  96. DE PERROT M
    Commentary: Is thoracic cage volume a new parameter for clinical staging in mesothelioma?
    J Thorac Cardiovasc Surg. 2020;159:2520-2521.
    PubMed    


  97. BURT BM, Lee HS, Raghuram AC, Strange C, et al
    Preoperative prediction of unresectability in malignant pleural mesothelioma.
    J Thorac Cardiovasc Surg. 2020;159:2512-2520.
    PubMed     Abstract available


  98. HYLTON DA, Turner S, Kidane B, Spicer J, et al
    The Canada Lymph Node Score for prediction of malignancy in mediastinal lymph nodes during endobronchial ultrasound.
    J Thorac Cardiovasc Surg. 2020;159:2499-2507.
    PubMed     Abstract available


  99. VIEIRA A, Bourdages-Pageau E, Kennedy K, Ugalde PA, et al
    The learning curve on uniportal video-assisted thoracic surgery: An analysis of proficiency.
    J Thorac Cardiovasc Surg. 2020;159:2487-2495.
    PubMed     Abstract available


    May 2020
  100. DONINGTON JS, Paulus R, Edelman MJ, Krasna MJ, et al
    Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 31. pii: S0022-5223(20)31276.
    PubMed     Abstract available


  101. SESTI J, Paul S
    Commentary: More science, less fortunetelling: Using radiomics to predict the invasiveness of lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31268.
    PubMed    


  102. DIMOU A, Nasarre C, Peterson YK, Pagano R, et al
    Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31233.
    PubMed     Abstract available


  103. RAJARAM R, Rice DC, Li Y, Bruera E, et al
    Postoperative opioid use after lobectomy for primary lung cancer: A propensity-matched analysis of premier hospital data.
    J Thorac Cardiovasc Surg. 2020 May 16. pii: S0022-5223(20)31136.
    PubMed     Abstract available


  104. PASS HI
    Commentary: Not only SMART clinically, but translationally!
    J Thorac Cardiovasc Surg. 2020;159:2094-2095.
    PubMed    


  105. BRUNELLI A
    Commentary: The power of indeterminacy.
    J Thorac Cardiovasc Surg. 2020;159:2041.
    PubMed    


  106. SESTI J, Paul S
    Commentary: Known unknowns and unknown unknowns: The case of the indeterminate margin.
    J Thorac Cardiovasc Surg. 2020;159:2042.
    PubMed    


  107. CHEN-YOSHIKAWA TF
    Commentary: A journey of a thousand miles begins with a single step.
    J Thorac Cardiovasc Surg. 2020;159:2092-2093.
    PubMed    


  108. SRINATHAN S
    Is ventilatory efficiency the next new thing in prehabilitation?
    J Thorac Cardiovasc Surg. 2020;159:e323-e324.
    PubMed    


  109. WAKEAM E, Adibfar A, Stokes S, Leighl NB, et al
    Defining the role of adjuvant therapy for early-stage large cell neuroendocrine carcinoma.
    J Thorac Cardiovasc Surg. 2020;159:2043-2054.
    PubMed     Abstract available


  110. MOLINA JC, Chaudry F, Menezes V, Ferraro P, et al
    Transvascular endosonographic-guided needle biopsy of intrathoracic lesions.
    J Thorac Cardiovasc Surg. 2020;159:2057-2065.
    PubMed     Abstract available


    April 2020
  111. DONINGTON J
    Commentary: Why does neoadjuvant therapy suddenly make sense for early stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2020 Apr 25. pii: S0022-5223(20)30999.
    PubMed    


  112. DENLINGER CE
    Commentary: Durable activity of a tyrosine kinase inhibitor in lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 23. pii: S0022-5223(20)30985.
    PubMed    


  113. AZZOLI CG, Ng T
    Commentary: Preoperative gefitinib for stage II-III non-small cell lung cancer with EGFR mutation: A stich in time, or delay from stiches?
    J Thorac Cardiovasc Surg. 2020 Apr 18. pii: S0022-5223(20)30967.
    PubMed    


  114. HOANG CD
    Commentary: Smoke or fire? Resected lung cancer in never-smokers.
    J Thorac Cardiovasc Surg. 2020 Apr 10. pii: S0022-5223(20)30795.
    PubMed    


  115. LIM K, Hsin MKY
    Commentary: Resection for small cell lung cancer should be offered more often, and preferably anatomical.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30780.
    PubMed    


  116. JEFFREY YANG CF
    Commentary: Is surgery better than chemoradiation for T3N1M0 non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30805.
    PubMed    


  117. HATTORI A, Suzuki K, Takamochi K, Wakabayashi M, et al
    Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Apr 6. pii: S0022-5223(20)30734.
    PubMed     Abstract available


  118. LANUTI M
    Commentary: Wedge resection for limited-stage small cell lung cancer: Not an acceptable modality for curative intent.
    J Thorac Cardiovasc Surg. 2020 Apr 5. pii: S0022-5223(20)30811.
    PubMed    


  119. PASS HI
    Commentary: "Hot" gene signatures for checkpoint response prediction: A very cool idea.
    J Thorac Cardiovasc Surg. 2020;159:1611-1612.
    PubMed    


  120. WAKEAM E, Kidane B
    Commentary: Picking the winners-Leaning into selection bias.
    J Thorac Cardiovasc Surg. 2020;159:1594-1595.
    PubMed    


  121. BLESSING WA, Colson YL
    Commentary: The checkpoint before checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2020;159:1614-1615.
    PubMed    


  122. PATEL S, Kim AW
    Commentary: TiME may actually tell good from bad.
    J Thorac Cardiovasc Surg. 2020;159:1613-1614.
    PubMed    


  123. PASS HI
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1609-1610.
    PubMed    


  124. WOLF AS
    Discussion.
    J Thorac Cardiovasc Surg. 2020;159:1556.
    PubMed    


  125. SUBRAMANIAN MP
    Commentary: Much to do about nodules-Improving care with a multidisciplinary pulmonary nodule clinic.
    J Thorac Cardiovasc Surg. 2020;159:1569-1570.
    PubMed    


  126. PARK CH, Lee SM, Lee JW, Hwang SH, et al
    Hook-wire localization versus lipiodol localization for patients with pulmonary lesions having ground-glass opacity.
    J Thorac Cardiovasc Surg. 2020;159:1571-1579.
    PubMed     Abstract available


  127. NGUYEN DM, Villamizar N
    Commentary: Preoperative localization of "hard-to-find" pulmonary ground-glass opacity: There are more than one way to find the target.
    J Thorac Cardiovasc Surg. 2020;159:1581-1583.
    PubMed    


  128. MADARIAGA ML, Lennes IT, Best T, Shepard JO, et al
    Multidisciplinary selection of pulmonary nodules for surgical resection: Diagnostic results and long-term outcomes.
    J Thorac Cardiovasc Surg. 2020;159:1558-1566.
    PubMed     Abstract available


  129. FELMLY LM, Gibney BC
    Commentary: Biphasic malignant mesothelioma-Survival of the fittest.
    J Thorac Cardiovasc Surg. 2020;159:1596-1597.
    PubMed    


  130. SESTI J, Paul S
    Commentary: GGOogle maps for the adult lung.
    J Thorac Cardiovasc Surg. 2020;159:1580.
    PubMed    


  131. LOCOCO F, Torricelli F, Lang-Lazdunski L, Veronesi G, et al
    Survival results in biphasic malignant pleural mesothelioma patients: A multicentric analysis.
    J Thorac Cardiovasc Surg. 2020;159:1584-1593.
    PubMed     Abstract available


    March 2020
  132. OPITZ I
    Commentary: Surgery expanding to stage IV non-small cell lung cancer treatment?!
    J Thorac Cardiovasc Surg. 2020 Mar 31. pii: S0022-5223(20)30731.
    PubMed    


  133. MITCHELL KG, Farooqi A, Ludmir EB, Corsini EM, et al
    Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30633.
    PubMed     Abstract available


  134. XIE D, Deng J, Gonzalez-Rivas D, Zhu Y, et al
    Comparison of video-assisted thoracoscopic surgery with thoracotomy in bronchial sleeve lobectomy for centrally located non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 25. pii: S0022-5223(20)30719.
    PubMed     Abstract available


  135. CHAN EG, Chan PG, Mazur SN, Normolle DP, et al
    Outcomes with segmentectomy versus lobectomy in patients with clinical T1cN0M0 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30706.
    PubMed     Abstract available


  136. PATNAIK SK, Cortes EG, Kannisto ED, Punnanitinont A, et al
    Lower airway bacterial microbiome may influence recurrence after resection of early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 23. pii: S0022-5223(20)30631.
    PubMed     Abstract available


  137. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    The effect of extent of resection on outcomes in patients with limited stage small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 22. pii: S0022-5223(20)30634.
    PubMed     Abstract available


  138. CHOI JJ, Huang J
    Commentary: How much is enough? The extent of resection in small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30588.
    PubMed    


  139. PASS HI
    Commentary: Lung cancer and dysbiosis: Debugging the studies for the future.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30619.
    PubMed    


  140. ZHANG Y, Fu F, Hu H, Wang S, et al
    Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non-small cell lung cancer: A phase II study.
    J Thorac Cardiovasc Surg. 2020 Mar 19. pii: S0022-5223(20)30625.
    PubMed     Abstract available


    February 2020
  141. HONG TH, Kim J, Shin S, Kim HK, et al
    Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Feb 29. pii: S0022-5223(20)30518.
    PubMed     Abstract available


  142. RAHOUMA M, Kamel M, Nasar A, Harrison S, et al
    Treatment of cT3N1M0/IIIA non-small cell lung cancer and the risk of underuse of surgery.
    J Thorac Cardiovasc Surg. 2020 Feb 24. pii: S0022-5223(20)30503.
    PubMed     Abstract available


  143. JAKLITSCH MT, Jacobson FL
    The future of lung cancer screening with low-dose computed tomography.
    J Thorac Cardiovasc Surg. 2020 Feb 19. pii: S0022-5223(20)30199.
    PubMed    


  144. NGUYEN DM, Villamizar N
    Commentary: Lower airway microbiome and non-small cell lung cancer: The beginning of a bug story.
    J Thorac Cardiovasc Surg. 2020 Feb 14. pii: S0022-5223(20)30382.
    PubMed    


  145. NELSON DB, Niu J, Mitchell KG, Antonoff MB, et al
    Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020;159:691-702.
    PubMed     Abstract available


  146. BOTT MJ
    Commentary: Opioid dependence in the lobectomy patient: A hard pill to swallow.
    J Thorac Cardiovasc Surg. 2020;159:703-704.
    PubMed    


  147. BACIEWICZ FA JR
    Preoperative pulmonary rehabilitation.
    J Thorac Cardiovasc Surg. 2020;159:e147-e148.
    PubMed    


  148. LINDEN PA, Perry Y, Worrell S, Wallace A, et al
    Postoperative day 1 discharge after anatomic lung resection: A Society of Thoracic Surgeons database analysis.
    J Thorac Cardiovasc Surg. 2020;159:667-678.
    PubMed     Abstract available


    January 2020
  149. ZHANG Y, Chen C, Hu J, Han Y, et al
    Early outcomes of robotic versus thoracoscopic segmentectomy for early-stage lung cancer: A multi-institutional propensity score-matched analysis.
    J Thorac Cardiovasc Surg. 2020 Jan 25. pii: S0022-5223(20)30226.
    PubMed     Abstract available


  150. WIESEL O, Burt BM
    Commentary: The A, C, G, and Ts of differentiating stage I and stage IV lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 17. pii: S0022-5223(19)37103.
    PubMed    


  151. LIN J
    Commentary: Through the looking glass: Is the consolidation/tumor ratio more important than size for clinical T1N0 lung cancer with a dominant ground-glass opacity?
    J Thorac Cardiovasc Surg. 2020 Jan 11. pii: S0022-5223(20)30071.
    PubMed    


  152. ITO H, Suzuki K, Mizutani T, Aokage K, et al
    Long-term survival outcome after lobectomy in patients with clinical T1 N0 lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 11. pii: S0022-5223(20)30054.
    PubMed     Abstract available


  153. RANDHAWA SK, Puri V
    Commentary: The changing risk paradigm in lung cancer: Are we opening Pandora's box?
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43494.
    PubMed    


  154. CHIDI A, Broderick SR
    Commentary: Chemo if you can-disparities in receipt of guideline-concordant adjuvant therapy in patients with locoregional non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43489.
    PubMed    


    December 2019
  155. WU J, Bai HX, Chan L, Su C, et al
    Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
    J Thorac Cardiovasc Surg. 2019 Dec 26. pii: S0022-5223(19)41497.
    PubMed     Abstract available


  156. YANG CJ, Berry MF
    Commentary: Resection of clinical early-stage lung cancer with unexpected nodal disease-can less really be the same?
    J Thorac Cardiovasc Surg. 2019 Dec 26. pii: S0022-5223(19)41495.
    PubMed    


  157. WHYTE RI
    Commentary: On-demand computed tomography screening for lung cancer-some surprising results.
    J Thorac Cardiovasc Surg. 2019 Dec 24. pii: S0022-5223(19)40870.
    PubMed    


  158. ZHENG R, Shen Q, Mardekian S, Solomides C, et al
    Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Dec 20. pii: S0022-5223(19)39883.
    PubMed     Abstract available


  159. BOYS J, Onaitis M
    Commentary: Breaking down non-small cell lung cancer tumor microenvironment heterogeneity and predicting response to immune checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2019 Dec 16. pii: S0022-5223(19)36852.
    PubMed    


  160. BRUNELLI A
    Commentary: Soft prognosticators following radical treatment of lung cancer: The time has come for a more integrated approach.
    J Thorac Cardiovasc Surg. 2019 Dec 14. pii: S0022-5223(19)37105.
    PubMed    


  161. LEE IH, Chen CY
    Commentary: The role of low-dose computed tomography for lung cancer screening among the nonsmoking Asian population.
    J Thorac Cardiovasc Surg. 2019 Dec 12. pii: S0022-5223(19)37081.
    PubMed    


  162. RHODIN KE, Rucker AJ, Ready NE, D'Amico TA, et al
    The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons.
    J Thorac Cardiovasc Surg. 2019 Dec 10. pii: S0022-5223(19)32182.
    PubMed     Abstract available


  163. NWOGU CE
    Commentary: Are two local therapies better than one for early-stage small cell lung cancer?
    J Thorac Cardiovasc Surg. 2019;158:1679.
    PubMed    


  164. SIHAG S
    Commentary: Surgery for N3 disease: Next frontier or has this ship already sailed?
    J Thorac Cardiovasc Surg. 2019;158:1695-1697.
    PubMed    


  165. YANG SC
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1675-1677.
    PubMed    


  166. HUANG J
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1691-1692.
    PubMed    


    November 2019
  167. VIEIRA A, Ugalde PA
    Commentary: Sleeve lobectomy for centrally located non-small cell lung cancer: Should the approach be a matter of debate?
    J Thorac Cardiovasc Surg. 2019 Nov 30. pii: S0022-5223(19)34024.
    PubMed    


  168. CHEN KN
    Commentary: Pay attention to low-risk populations for lung cancer, but cautiously interpret ground-glass nodules screened by low-dose computed tomography scan.
    J Thorac Cardiovasc Surg. 2019 Nov 27. pii: S0022-5223(19)33476.
    PubMed    


  169. PALEIRON N, Grassin F, Lancelin C, Tromeur C, et al
    Assessment of preoperative noninvasive ventilation before lung cancer surgery: The preOVNI randomized controlled study.
    J Thorac Cardiovasc Surg. 2019 Nov 23. pii: S0022-5223(19)33106.
    PubMed     Abstract available


  170. QIU T, Zhao Y, Xuan Y, Qin Y, et al
    Robotic sleeve lobectomy for centrally located non-small cell lung cancer: A propensity score-weighted comparison with thoracoscopic and open surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 22. pii: S0022-5223(19)33072.
    PubMed     Abstract available


  171. RAZI SS, Nguyen D, Villamizar N
    Lobectomy does not confer survival advantage over segmentectomy for non-small cell lung cancer with unsuspected nodal disease.
    J Thorac Cardiovasc Surg. 2019 Nov 21. pii: S0022-5223(19)33080.
    PubMed     Abstract available


  172. FARROW NE, An SJ, Speicher PJ, Harpole DH Jr, et al
    Disparities in guideline-concordant treatment for node-positive, non-small cell lung cancer following surgery.
    J Thorac Cardiovasc Surg. 2019 Nov 13. pii: S0022-5223(19)32486.
    PubMed     Abstract available


  173. JANG HJ, Lee HS, Ramos D, Park IK, et al
    Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors.
    J Thorac Cardiovasc Surg. 2019 Nov 11. pii: S0022-5223(19)32515.
    PubMed     Abstract available


  174. PARK S, Ahn HJ, Yang M, Kim JA, et al
    The prognostic nutritional index and postoperative complications after curative lung cancer resection: A retrospective cohort study.
    J Thorac Cardiovasc Surg. 2019 Nov 6. pii: S0022-5223(19)32490.
    PubMed     Abstract available


  175. TITAN AL, He H, Lui N, Liou D, et al
    The influence of hormone replacement therapy on lung cancer incidence and mortality.
    J Thorac Cardiovasc Surg. 2019 Nov 5. pii: S0022-5223(19)32348.
    PubMed     Abstract available


  176. BRODERICK SR, Bott MJ
    Neoadjuvant immunotherapy in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019;158:1471-1474.
    PubMed    


  177. KNEUERTZ PJ, Cheufou DH, D'Souza DM, Mardanzai K, et al
    Propensity-score adjusted comparison of pathologic nodal upstaging by robotic, video-assisted thoracoscopic, and open lobectomy for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019;158:1457-1466.
    PubMed     Abstract available


  178. BERRY MF
    Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1465-1466.
    PubMed    


  179. CERFOLIO RJ
    Commentary: Do we have the right combatants? Should it be minimally invasive surgery versus therapy that removes no lymph nodes?
    J Thorac Cardiovasc Surg. 2019;158:1467-1468.
    PubMed    


  180. GONZALEZ-RIVAS D, Rami-Porta R
    Commentary: Intraoperative lymph node assessment by robotic, video-assisted thoracoscopic surgery, and thoracotomy: None meet the international recommendations.
    J Thorac Cardiovasc Surg. 2019;158:1469-1470.
    PubMed    


    October 2019
  181. KOZOWER BD
    Commentary: The association between hormone-replacement therapy and non-small cell lung cancer in women.
    J Thorac Cardiovasc Surg. 2019 Oct 15. pii: S0022-5223(19)32198.
    PubMed    


  182. KOZOWER BD
    Commentary: Lung cancer resection in the United States: Is regionalization the answer?
    J Thorac Cardiovasc Surg. 2019 Oct 15. pii: S0022-5223(19)32200.
    PubMed    


  183. LIU R, Kidane B
    Commentary: Detection is only part of the equation-Does elevated risk alone warrant screening?
    J Thorac Cardiovasc Surg. 2019;158:1255-1256.
    PubMed    



  184. Discussion.
    J Thorac Cardiovasc Surg. 2019;158:1240-1241.
    PubMed    


    September 2019
  185. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    The influence of adjuvant therapy on survival in patients with indeterminate margins following surgery for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 30. pii: S0022-5223(19)32082.
    PubMed     Abstract available


  186. SEPESI B, Cascone T
    Commentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time?
    J Thorac Cardiovasc Surg. 2019 Sep 24. pii: S0022-5223(19)32035.
    PubMed    


  187. ABBAS AE
    Commentary: Robotic anatomic lung resection: Raising the bar of our expectations in treating lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 24. pii: S0022-5223(19)32045.
    PubMed    


  188. SEPESI B
    Commentary: Surgery for N3 non-small cell lung cancer-utopia or future reality?
    J Thorac Cardiovasc Surg. 2019 Sep 23. pii: S0022-5223(19)31929.
    PubMed    


  189. TAYLOR M, Okereke I
    Commentary: Is radiation needed after resecting an early-stage small cell lung cancer?
    J Thorac Cardiovasc Surg. 2019 Sep 20. pii: S0022-5223(19)31888.
    PubMed    


  190. ALTORKI N, Stiles B
    Commentary: High-dose induction chemoradiation for lung cancer: The past is prologue.
    J Thorac Cardiovasc Surg. 2019 Sep 20. pii: S0022-5223(19)31873.
    PubMed    


  191. CAO C, Louie BE, Melfi F, Veronesi G, et al
    Outcomes of major complications after robotic anatomic pulmonary resection.
    J Thorac Cardiovasc Surg. 2019 Sep 18. pii: S0022-5223(19)31809.
    PubMed     Abstract available


  192. RAMAN V, Jawitz OK, Yang CJ, Voigt SL, et al
    Outcomes of surgery versus chemoradiotherapy in patients with clinical or pathologic stage N3 non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31760.
    PubMed     Abstract available


  193. ENGELHARDT KE, Coughlin JM, DeCamp MM, Denlinger CE, et al
    Survival after adjuvant radiation therapy in localized small cell lung cancer treated with complete resection.
    J Thorac Cardiovasc Surg. 2019 Sep 9. pii: S0022-5223(19)31758.
    PubMed     Abstract available


  194. BOTT MJ
    Commentary: Cell proliferation and immune evasion: A dangerous combination.
    J Thorac Cardiovasc Surg. 2019;158:920-921.
    PubMed    


  195. DUX J, Grosser R, Adusumilli PS
    Commentary: Return to intended radiation therapy-Criteria for resection?
    J Thorac Cardiovasc Surg. 2019;158:930-931.
    PubMed    


    August 2019
  196. JIANG L, Huang W, Liu J, Harris K, et al
    Endosonography with lymph node sampling for restaging the mediastinum in lung cancer: A systematic review and pooled data analysis.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31649.
    PubMed     Abstract available


  197. YAMAMICHI T, Shimada Y, Masuno R, Ohira T, et al
    Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
    J Thorac Cardiovasc Surg. 2019 Aug 28. pii: S0022-5223(19)31659.
    PubMed     Abstract available


  198. PANI E, Kennedy G, Zheng X, Ukert B, et al
    Factors associated with nodal metastasis in 2-centimeter or less non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Aug 25. pii: S0022-5223(19)31643.
    PubMed     Abstract available


    July 2019
  199. DONINGTON JS, Martin LW
    Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2019;158:287-288.
    PubMed    


  200. MOLINA JC, Liberman M
    Commentary: Pulling an entire lung out of a small incision-Video-assisted thoracoscopic surgical pneumonectomy, the final frontier in minimally invasive thoracic surgery.
    J Thorac Cardiovasc Surg. 2019;158:267-268.
    PubMed    


    May 2019
  201. LUI NS
    Commentary: Should lung cancer screening guidelines go up in smoke?
    J Thorac Cardiovasc Surg. 2019 May 31. pii: S0022-5223(19)31140.
    PubMed    


  202. GROTH SS, Ripley RT, Carrott P, Burt BM, et al
    Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma.
    J Thorac Cardiovasc Surg. 2019 May 30. pii: S0022-5223(19)31150.
    PubMed    


  203. KOZOWER BD
    Commentary: Invasive mediastinal staging for patients with lung cancer-We need to do better!
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31112.
    PubMed    


  204. FARJAH F, Silvestri GA, Wood DE
    Commentary: Invasive mediastinal staging for lung cancer-Quality gap, evidence gap, both?
    J Thorac Cardiovasc Surg. 2019 May 24. pii: S0022-5223(19)31113.
    PubMed    


  205. BRAVO-INIGUEZ CE, Fox SW, De Leon LE, Tarascio JN, et al
    Cumulative nonsmoking risk factors increase the probability of developing lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 18. pii: S0022-5223(19)31038.
    PubMed     Abstract available


  206. MITCHELL KG, Parra ER, Nelson DB, Zhang J, et al
    Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 May 17. pii: S0022-5223(19)31015.
    PubMed     Abstract available


  207. LUI NS
    Commentary: Pleomorphic carcinoma: An aggressive type of non-small cell lung cancer that should be treated like the others.
    J Thorac Cardiovasc Surg. 2019 May 16. pii: S0022-5223(19)31004.
    PubMed    


  208. NELSON DB, Tayob N, Nguyen QN, Erasmus J, et al
    Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2019 May 11. pii: S0022-5223(19)30972.
    PubMed     Abstract available


  209. OSAROGIAGBON RU, Lee YS, Faris NR, Ray MA, et al
    Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    J Thorac Cardiovasc Surg. 2019 May 2. pii: S0022-5223(19)30968.
    PubMed     Abstract available


  210. PREDINA JD, Newton AD, Corbett C, Shin M, et al
    Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas.
    J Thorac Cardiovasc Surg. 2019;157:2061-2069.
    PubMed     Abstract available


  211. KAMEL MK, Lee B, Harrison S, Port JL, et al
    Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice?
    J Thorac Cardiovasc Surg. 2019;157:2038-2046.
    PubMed     Abstract available


    April 2019
  212. LANUTI M
    Commentary: Cautious optimism for induction immunotherapy in resectable lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30926.
    PubMed    


  213. ALTORKI N, Lee B
    Commentary: Lobectomy or sublobar resection for early lung cancer: One small step for surgeons, one giant step for patients.
    J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30903.
    PubMed    


  214. HENDRIKSEN BS, Hollenbeak CS, Reed MF, Taylor MD, et al
    Perioperative chemotherapy is not associated with improved survival in stage I pleomorphic lung cancer.
    J Thorac Cardiovasc Surg. 2019 Apr 17. pii: S0022-5223(19)30824.
    PubMed     Abstract available


    March 2019
  215. MOORE CB, Cox ML, Mulvihill MS, Klapper J, et al
    Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 28. pii: S0022-5223(19)30702.
    PubMed     Abstract available


  216. NELSON DB, Mehran RJ, Mitchell KG, Correa AM, et al
    Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Mar 21. pii: S0022-5223(19)30677.
    PubMed     Abstract available


  217. SUBRAMANIAN M, Liu J, Greenberg C, Schumacher J, et al
    Imaging Surveillance for Surgically Resected Stage I Non-Small Cell Lung Cancer: Is More Always Better?
    J Thorac Cardiovasc Surg. 2019;157:1205-1217.
    PubMed     Abstract available


  218. ODELL DD, Feinglass J, Engelhardt K, Papastefan S, et al
    Evaluation of adherence to the Commission on Cancer lung cancer quality measures.
    J Thorac Cardiovasc Surg. 2019;157:1219-1235.
    PubMed     Abstract available



  219. Discussion.
    J Thorac Cardiovasc Surg. 2019;157:1231-1235.
    PubMed    


    February 2019
  220. STILES BM, Mao J, Harrison S, Lee B, et al
    Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2019 Feb 28. pii: S0022-5223(19)30533.
    PubMed     Abstract available


  221. VAN BERKEL V
    Commentary: Still not enough data yet-Sublobar resection versus lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30461.
    PubMed    


  222. GRAVIER FE, Bonnevie T, Boujibar F, Medrinal C, et al
    Effect of prehabilitation on ventilatory efficiency in non-small cell lung cancer patients: A cohort study.
    J Thorac Cardiovasc Surg. 2019 Feb 19. pii: S0022-5223(19)30448.
    PubMed     Abstract available


  223. LATIF MJ, Tan KS, Molena D, Huang J, et al
    Perioperative blood transfusion has a dose-dependent relationship with disease recurrence and survival in patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Feb 12. pii: S0022-5223(19)30351.
    PubMed     Abstract available


    January 2019
  224. SALTER KD, Burt BM
    Commentary: Postoperative blood transplantation for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Jan 25. pii: S0022-5223(19)30259.
    PubMed    


  225. GUCKENBERGER M, Aerts JG, Van Schil P, Weder W, et al
    The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion.
    J Thorac Cardiovasc Surg. 2019;157:358-361.
    PubMed    


  226. GROTH SS, Ripley RT, Burt BM
    A thinner peel to peel: Pleural thickness is prognostic in mesothelioma.
    J Thorac Cardiovasc Surg. 2019;157:414-415.
    PubMed    


  227. SEMENKOVICH TR, Puri V
    Surgery versus stereotactic body radiation therapy: Definitive evidence is still elusive.
    J Thorac Cardiovasc Surg. 2019;157:374-375.
    PubMed    


  228. OKADA M, Miyata Y, Takamochi K, Tsutani Y, et al
    Prospective feasibility study of sealing pulmonary vessels with energy in lung surgery.
    J Thorac Cardiovasc Surg. 2019;157:388-395.
    PubMed     Abstract available


    December 2018
  229. SAMSON P
    It's time to check our bias: Ensuring health equity for patients with lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 27. pii: S0022-5223(18)33499.
    PubMed    


  230. HSIN MK, Ho JC
    It is not as bad as they say: The risks of surgery in screening-detected lung cancer are overstated.
    J Thorac Cardiovasc Surg. 2018 Dec 25. pii: S0022-5223(18)33482.
    PubMed    


  231. YANG CJ, Yendamuri S, Mayne NR, Battoo A, et al
    The role of thoracoscopic pneumonectomy in the management of non-small cell lung cancer: A multicenter study.
    J Thorac Cardiovasc Surg. 2018 Dec 18. pii: S0022-5223(18)33419.
    PubMed     Abstract available


  232. BOTT MJ, Yang SC, Park BJ, Adusumilli PS, et al
    Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Dec 13. pii: S0022-5223(18)33277.
    PubMed     Abstract available


  233. WOLF A, Alpert N, Tran BV, Liu B, et al
    Persistence of racial disparities in early-stage lung cancer treatment.
    J Thorac Cardiovasc Surg. 2018 Dec 11. pii: S0022-5223(18)33258.
    PubMed     Abstract available


  234. FERRARI-LIGHT D, Cerfolio RJ
    Are we really operating on advanced stage non-small cell lung cancer?
    J Thorac Cardiovasc Surg. 2018 Dec 4. pii: S0022-5223(18)33219.
    PubMed    


  235. OKAMURA A, Watanabe M, Hayami M, Mine S, et al
    Esophagectomy via upper partial sternotomy for esophageal cancer after previous right pneumonectomy: A case report.
    J Thorac Cardiovasc Surg. 2018;156:e217-e220.
    PubMed    


    November 2018
  236. FERNANDEZ FG, Kosinski AS, Tong BC, Furnary AP, et al
    Lack of correlation between short- and long-term performance after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018 Nov 27. pii: S0022-5223(18)33141.
    PubMed     Abstract available


  237. NELSON DB, Tayob N, Mitchell KG, Correa AM, et al
    Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.
    J Thorac Cardiovasc Surg. 2018 Nov 26. pii: S0022-5223(18)33149.
    PubMed     Abstract available


  238. DAVID EA, Andersen SW, Beckett LA, Melnikow J, et al
    Survival benefits associated with surgery for advanced non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 14. pii: S0022-5223(18)32941.
    PubMed     Abstract available


  239. DONINGTON JS
    Keeping surgery relevant in oligometastatic non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Nov 8. pii: S0022-5223(18)32903.
    PubMed    


  240. HARRISON MS, Frye CC, Puri V
    Health metrics in lung cancer care: Measure, improve, repeat.
    J Thorac Cardiovasc Surg. 2018 Nov 2. pii: S0022-5223(18)32879.
    PubMed    


    October 2018
  241. KORST RJ, Santana-Joseph S
    Quality metrics for lung cancer care: Far from perfect, but close to reality.
    J Thorac Cardiovasc Surg. 2018 Oct 28. pii: S0022-5223(18)32858.
    PubMed    


  242. SUBRAMANIAN MP, Puri V
    Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.
    J Thorac Cardiovasc Surg. 2018 Oct 26. pii: S0022-5223(18)32833.
    PubMed    


  243. FARJAH F, Kessler L
    Rightsizing lung cancer surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 22. pii: S0022-5223(18)32803.
    PubMed    


  244. ZHANG Y, Chen H
    Neoadjuvant or adjuvant chemotherapy for non-small-cell lung cancer: Does the timing matter?
    J Thorac Cardiovasc Surg. 2018 Oct 12. pii: S0022-5223(18)32632.
    PubMed    


  245. BRUNELLI A
    The timing of chemotherapy in multimodality treatment of locally advanced lung cancer: One size does not fit all.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32609.
    PubMed    


  246. BRANDT WS, Yan W, Zhou J, Tan KS, et al
    Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32606.
    PubMed     Abstract available


  247. WANG Y, Yeung JC, Hanna WC, Allison F, et al
    Metachronous or synchronous primary lung cancer in the era of computed tomography surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 6. pii: S0022-5223(18)32556.
    PubMed     Abstract available


    September 2018
  248. CAO C, Wang D, Chung C, Tian D, et al
    A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Sep 15. pii: S0022-5223(18)32347.
    PubMed     Abstract available


  249. ENGELHARDT KE, Feinglass JM, DeCamp MM, Bilimoria KY, et al
    Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time-trend analysis of the National Cancer Data Base.
    J Thorac Cardiovasc Surg. 2018;156:1233-1246.
    PubMed     Abstract available


    August 2018
  250. FERNANDEZ-RODRIGUEZ L, Torres I, Romera D, Galera R, et al
    Prediction of postoperative lung function after major lung resection for lung cancer using volumetric computed tomography.
    J Thorac Cardiovasc Surg. 2018 Aug 2. pii: S0022-5223(18)32018.
    PubMed     Abstract available


    July 2018
  251. LIN J, Fernandez F
    Indications for invasive mediastinal staging for non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Jul 21. pii: S0022-5223(18)31872.
    PubMed    


  252. HOANG CD
    Adjuvant chemotherapy in stage I lung cancer: Is more better?
    J Thorac Cardiovasc Surg. 2018 Jul 19. pii: S0022-5223(18)31821.
    PubMed    


  253. WANG S, Xu J, Wang R, Qian F, et al
    Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    J Thorac Cardiovasc Surg. 2018 Jul 18. pii: S0022-5223(18)31779.
    PubMed     Abstract available


  254. UPHAM TC, Onaitis MW
    Video-assisted thoracoscopic surgery versus robot-assisted thoracoscopic surgery versus thoracotomy for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;156:365-368.
    PubMed    


    June 2018
  255. SCHRUMP DS, Hong JA
    Analysis of circulating tumor DNA: The next paradigm shift in detection and treatment of lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2632-2633.
    PubMed    


    May 2018
  256. HATTORI A, Suzuki K
    New era defining a novel clinical T staging in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:2179-2180.
    PubMed    


    April 2018
  257. SWANSON SJ
    Good vibrations-better care for lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Apr 13. pii: S0022-5223(18)30994.
    PubMed    


  258. BRUNELLI A
    It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30962.
    PubMed    


  259. OKIROR L, Harling L, Toufektzian L, King J, et al
    Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30935.
    PubMed     Abstract available


  260. CAO J, Xu J, He Z, Yuan P, et al
    Prognostic impact of lymphadenectomy on outcomes of sublobar resection for stage IA non-small cell lung cancer </=2 cm.
    J Thorac Cardiovasc Surg. 2018 Apr 6. pii: S0022-5223(18)30905.
    PubMed     Abstract available


  261. YENDAMURI S, Dhillon SS, Groman A, Dy G, et al
    Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection.
    J Thorac Cardiovasc Surg. 2018 Apr 4. pii: S0022-5223(18)30895.
    PubMed     Abstract available


  262. MAO Q, Xia W, Dong G, Chen S, et al
    A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
    J Thorac Cardiovasc Surg. 2018;155:1784-1792.
    PubMed     Abstract available


    March 2018
  263. KRUSER TJ, Mohindra N, DeCamp MM
    One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer management.
    J Thorac Cardiovasc Surg. 2018 Mar 29. pii: S0022-5223(18)30865.
    PubMed    


  264. ISBELL JM, Jones DR, Li BT
    Circulating tumor DNA: A promising biomarker to guide postoperative treatment and surveillance of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30707.
    PubMed    


  265. AJMANI GS, Wang CH, Kim KW, Howington JA, et al
    Surgical quality of wedge resection affects overall survival in patients with early stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 13. pii: S0022-5223(18)30776.
    PubMed     Abstract available


  266. CAMERON RB
    Adherence to lung cancer surgical quality standards is critical for the survival of both our patients and our specialty.
    J Thorac Cardiovasc Surg. 2018 Mar 7. pii: S0022-5223(18)30612.
    PubMed    


  267. SU K, Gao S, Ying J, Zou S, et al
    Sequencing a super multiple synchronous lung cancer reveals a novel variant in driver gene ARID1B.
    J Thorac Cardiovasc Surg. 2018 Mar 6. pii: S0022-5223(18)30059.
    PubMed    


  268. ROCCO G
    Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.
    J Thorac Cardiovasc Surg. 2018 Mar 2. pii: S0022-5223(18)30604.
    PubMed    


  269. BRUNELLI A
    Short-term outcomes do not capture the real value of lung cancer surgery.
    J Thorac Cardiovasc Surg. 2018;155:1311-1312.
    PubMed    


  270. MEHRAN RJ, Martin LW, Roth JA
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:1307.
    PubMed    


    February 2018
  271. SEPESI B, Ye Y, Mitchell KG, Zhang L, et al
    Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.
    J Thorac Cardiovasc Surg. 2018 Feb 15. pii: S0022-5223(18)30372.
    PubMed     Abstract available


  272. CHENG X, Zheng D, Li Y, Li H, et al
    Tumor histology predicts mediastinal nodal status and may be used to guide limited lymphadenectomy in patients with clinical stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Feb 13. pii: S0022-5223(18)30362.
    PubMed     Abstract available


  273. MUNOZ-LARGACHA JA, Steiling KA, Kathuria H, Charlot M, et al
    Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30308.
    PubMed     Abstract available


  274. THORNBLADE LW, Wood DE, Mulligan MS, Farivar AS, et al
    Variability in invasive mediastinal staging for lung cancer: A multicenter regional study.
    J Thorac Cardiovasc Surg. 2018 Feb 9. pii: S0022-5223(18)30311.
    PubMed     Abstract available


  275. RUSTHOVEN CG, Jones BL, Kavanagh BD
    Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:810-811.
    PubMed    


    January 2018
  276. AHMAD U, Machuzak M
    Electric shock therapy for lung cancer: Taking palliation to the next level.
    J Thorac Cardiovasc Surg. 2018 Jan 31. pii: S0022-5223(18)30245.
    PubMed    


  277. MOGHANAKI D, Simone CB 2nd, Rimner A, Karas TZ, et al
    The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018;155:429-431.
    PubMed    


    December 2017
  278. NOMORI H, Shiraishi A, Cong Y, Shoji K, et al
    Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 26. pii: S0022-5223(17)33059.
    PubMed     Abstract available


  279. RUSCH VW, Chaft J, Hellmann M
    KEYNOTE-024: Unlocking a pathway to lung cancer cure?
    J Thorac Cardiovasc Surg. 2017 Dec 23. pii: S0022-5223(17)33029.
    PubMed    


  280. ROGERS LJ, Bleetman D, Messenger DE, Joshi NA, et al
    The impact of enhanced recovery after surgery (ERAS) protocol compliance on morbidity from resection for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32855.
    PubMed     Abstract available


  281. DRAKE JA, Sullivan JL, Weksler B
    Adjuvant chemotherapy improves survival in patients with completely resected T3N0 non-small cell lung cancer invading the chest wall.
    J Thorac Cardiovasc Surg. 2017 Dec 19. pii: S0022-5223(17)32857.
    PubMed     Abstract available


  282. DIGESU CS, Hachey KJ, Gilmore DM, Khullar OV, et al
    Long-term outcomes after near-infrared sentinel lymph node mapping in non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Dec 13. pii: S0022-5223(17)32505.
    PubMed     Abstract available


  283. BRUNELLI A
    Time of modeling survival of patients with stage III-N2 non-small cell lung cancer: Before or after surgery makes a difference.
    J Thorac Cardiovasc Surg. 2017 Dec 12. pii: S0022-5223(17)32837.
    PubMed    


    November 2017
  284. GELLER AD, Zheng H, Mathisen DJ, Wright CD, et al
    Relative incremental costs of complications of lobectomy for stage I non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 20. pii: S0022-5223(17)32702.
    PubMed     Abstract available


  285. NEGRAO MV, Quek K, Zhang J, Sepesi B, et al
    TRACERx: Tracking tumor evolution to impact the course of lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 16. pii: S0022-5223(17)32689.
    PubMed    


  286. FERNANDEZ FG, Kosinski AS, Furnary AP, Onaitis M, et al
    Differential effects of operative complications on survival after surgery for primary lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 13. pii: S0022-5223(17)32503.
    PubMed     Abstract available


  287. WEKSLER B
    Resection of pleural implants in patients with lung cancer should remain the exception rather than the rule.
    J Thorac Cardiovasc Surg. 2017 Nov 8. pii: S0022-5223(17)32459.
    PubMed    


  288. LIN J
    Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow?
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32471.
    PubMed    


  289. CHENG X, Chen H
    Commentary on the impacts of postoperative complications on survival after lung cancer surgery.
    J Thorac Cardiovasc Surg. 2017 Nov 6. pii: S0022-5223(17)32470.
    PubMed    


  290. ZHENG D, Ye T, Hu H, Zhang Y, et al
    Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Nov 3. pii: S0022-5223(17)32409.
    PubMed     Abstract available


  291. LIU M, Wigle D, Wampfler JA, Dai J, et al
    T category of non-small cell lung cancer invading the fissure to the adjacent lobe.
    J Thorac Cardiovasc Surg. 2017;154:1777-1783.
    PubMed     Abstract available


  292. LANUTI M
    Risk stratification for distant recurrence of resected early stage non-small cell lung cancer is under construction.
    J Thorac Cardiovasc Surg. 2017 Nov 1. pii: S0022-5223(17)32392.
    PubMed    


    October 2017
  293. MOLENA D
    Shining light on sentinel node assessment for lung cancer: Quality is superior to quantity.
    J Thorac Cardiovasc Surg. 2017 Oct 20. pii: S0022-5223(17)32331.
    PubMed    


    September 2017
  294. DETTERBECK FC
    The eighth edition TNM stage classification for lung cancer: What does it mean on main street?
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32136.
    PubMed    


  295. ZHANG Z, Mostofian F, Ivanovic J, Gilbert S, et al
    All grades of severity of postoperative adverse events are associated with prolonged length of stay after lung cancer resection.
    J Thorac Cardiovasc Surg. 2017 Sep 28. pii: S0022-5223(17)32135.
    PubMed     Abstract available


  296. TURNA A, Melek H, Kara HV, Kilic B, et al
    Validity of the updated European Society of Thoracic Surgeons staging guideline in lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Sep 27. pii: S0022-5223(17)32131.
    PubMed     Abstract available


  297. CERFOLIO RJ, Ghanim AF, Dylewski M, Veronesi G, et al
    The long-term survival of robotic lobectomy for non-small cell lung cancer: A multi-institutional study.
    J Thorac Cardiovasc Surg. 2017 Sep 18. pii: S0022-5223(17)31919.
    PubMed     Abstract available


  298. GILBERT CR, Ely R, Fathi JT, Louie BE, et al
    The economic impact of a nurse practitioner-directed lung cancer screening, incidental pulmonary nodule, and tobacco-cessation clinic.
    J Thorac Cardiovasc Surg. 2017 Sep 13. pii: S0022-5223(17)31890.
    PubMed     Abstract available


  299. SEDER CW
    Lung cancer screening is here to stay, but does it pay?
    J Thorac Cardiovasc Surg. 2017 Sep 12. pii: S0022-5223(17)31887.
    PubMed    


  300. ANTONOFF MB
    Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease?
    J Thorac Cardiovasc Surg. 2017 Sep 8. pii: S0022-5223(17)31866.
    PubMed    


  301. TONG BC
    Lung cancer screening: No more excuses.
    J Thorac Cardiovasc Surg. 2017 Sep 5. pii: S0022-5223(17)31853.
    PubMed    


  302. LIU C, Liu L
    Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134.
    PubMed    


  303. DIGESU CS, Colson YL
    A "green" light for staging in early lung cancer.
    J Thorac Cardiovasc Surg. 2017;154:1134-1136.
    PubMed    


  304. FLORES RM
    Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31820.
    PubMed    


  305. KIDANE B
    Stereotactic body radiation therapy versus video-assisted thoracoscopic surgery in stage I lung cancer: Honesty in the face of uncertainty.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31821.
    PubMed    


  306. HATTORI A, Matsunaga T, Takamochi K, Oh S, et al
    Prognostic impact of a ground glass opacity component in the clinical T classification of non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31798.
    PubMed     Abstract available


  307. BURT BM
    Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.
    J Thorac Cardiovasc Surg. 2017 Sep 1. pii: S0022-5223(17)31823.
    PubMed    


    August 2017
  308. CORNWELL LD, Echeverria AE, Samuelian J, Mayor J, et al
    Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer.
    J Thorac Cardiovasc Surg. 2017 Aug 16. pii: S0022-5223(17)31718.
    PubMed     Abstract available


    July 2017
  309. FERNANDEZ FG
    What are the gaps in quality measurement for lung cancer surgery?
    J Thorac Cardiovasc Surg. 2017 Jul 1. pii: S0022-5223(17)31367.
    PubMed    


    June 2017
  310. SCHAHEEN LW, D'Cunha J
    The slippery slope of nonoperative therapy in early-stage lung cancer.
    J Thorac Cardiovasc Surg. 2017 Jun 10. pii: S0022-5223(17)31178.
    PubMed    


  311. BRANDT WS, Isbell JM, Jones DR
    Defining quality in the surgical care of lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31171.
    PubMed    


    May 2017
  312. CHEN K, Zhang J, Guan T, Yang F, et al
    Comparison of plasma to tissue DNA mutations in surgical patients with non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 24. pii: S0022-5223(17)31084.
    PubMed     Abstract available


  313. ZHAO Y, Li G, Zhang Y, Hu H, et al
    Comparison of outcomes between muscle-sparing thoracotomy and video-assisted thoracic surgery in patients with cT1 N0 M0 lung cancer.
    J Thorac Cardiovasc Surg. 2017 May 20. pii: S0022-5223(17)31049.
    PubMed     Abstract available


  314. NGUYEN DM, Villamizar N
    "One-stop shop" tumor tattooing and sentinel lymph node mapping: A new paradigm for lung cancer therapy.
    J Thorac Cardiovasc Surg. 2017 May 17. pii: S0022-5223(17)30908.
    PubMed    


    April 2017
  315. WEKSLER B
    One in every 14 patients with early-stage lung cancer is not being treated!
    J Thorac Cardiovasc Surg. 2017 Apr 24. pii: S0022-5223(17)30850.
    PubMed    


  316. HOANG CD
    Protein-based prognostic biomarkers in lung cancer: Promise or pitfall?
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30851.
    PubMed    


  317. FERRARIS VA
    Interstitial lung disease and lung cancer: Decisions, precision, and tuna fish sandwiches.
    J Thorac Cardiovasc Surg. 2017 Apr 23. pii: S0022-5223(17)30848.
    PubMed    


  318. BURT BM
    Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin?
    J Thorac Cardiovasc Surg. 2017 Apr 12. pii: S0022-5223(17)30689.
    PubMed    


  319. BERRY MF
    Evidence for resection of sarcoma pulmonary metastases: More, but better?
    J Thorac Cardiovasc Surg. 2017 Apr 7. pii: S0022-5223(17)30658.
    PubMed    


  320. MCMURRY TL, Shah PM, Samson P, Robinson CG, et al
    Treatment of stage I non-small cell lung cancer: What's trending?
    J Thorac Cardiovasc Surg. 2017 Apr 5. pii: S0022-5223(17)30643.
    PubMed     Abstract available


  321. YEROKUN BA, Yang CJ, Gulack BC, Li X, et al
    A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30639.
    PubMed     Abstract available


  322. TSUTANI Y, Mimura T, Kai Y, Ito M, et al
    Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30635.
    PubMed     Abstract available


  323. SMELTZER MP, Lin CC, Kong FS, Jemal A, et al
    Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States.
    J Thorac Cardiovasc Surg. 2017 Apr 4. pii: S0022-5223(17)30604.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: